Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Bossi, AT Chan, L Licitra, A Trama… - Annals of …, 2021 - annalsofoncology.org
Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
[HTML][HTML] Systematic review and meta-analysis of the association between radiation therapy treatment volume and patient outcomes
JYA Kyaw, A Rendall, EF Gillespie, T Roques… - International Journal of …, 2023 - Elsevier
Purpose Evidence of a volume–outcome association in cancer surgery has shaped the
centralization of cancer services; however, it is unknown whether a similar association exists …
centralization of cancer services; however, it is unknown whether a similar association exists …
[HTML][HTML] Nasopharyngeal carcinoma. A “different” head and neck tumour. Part B: treatment, prognostic factors, and outcomes
G Cantù - Acta Otorhinolaryngologica Italica, 2023 - ncbi.nlm.nih.gov
Nasopharyngeal carcinoma (NPC) is the most interesting and intriguing malignant tumour
located in the nasopharynx, because it is a “peculiar” malignancy,“different” from almost all …
located in the nasopharynx, because it is a “peculiar” malignancy,“different” from almost all …
CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal carcinoma
M Li, Y Li, M Yu - OncoTargets and therapy, 2020 - Taylor & Francis
Background Circular RNAs (circRNAs) and microRNAs (miRNAs) have been reported to act
as the important regulators in nasopharyngeal carcinoma (NPC). CircRNA ZNF609 (circ …
as the important regulators in nasopharyngeal carcinoma (NPC). CircRNA ZNF609 (circ …
The impact of facility type and volume on treatment and overall survival in craniopharyngioma
Background Craniopharyngiomas are uncommon benign sellar and parasellar tumors with
high overall survival (OS) and recurrence rates. Treatment is often surgical but may include …
high overall survival (OS) and recurrence rates. Treatment is often surgical but may include …
Sinonasal squamous cell carcinoma outcomes: does treatment at a high-volume center confer survival benefit?
JI Teitelbaum, K Issa, IR Barak… - … –Head and Neck …, 2020 - journals.sagepub.com
Objective To determine whether treatment of sinonasal squamous cell carcinoma (SCC) at a
high-volume facility affects survival. Study Design Retrospective database analysis. Setting …
high-volume facility affects survival. Study Design Retrospective database analysis. Setting …
The influence of facility volume and type on skull base chordoma treatment and outcomes
Objective To evaluate the influence of facility case volume and type on skull base chordoma
treatment and overall survival (OS). Methods The 2004–2016 National Cancer Database …
treatment and overall survival (OS). Methods The 2004–2016 National Cancer Database …
Academic affiliation and surgical volume predict survival in head and neck cancer patients receiving surgery
Objective To determine whether the academic affiliation or surgical volume affects the
overall survival (OS) of human papillomavirus (HPV)–negative head and neck squamous …
overall survival (OS) of human papillomavirus (HPV)–negative head and neck squamous …
Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma
Background Treatment at high‐volume surgical facilities (HVSFs) provides a survival benefit
for patients with head and neck squamous cell carcinomas (HNSCCs); however, it is …
for patients with head and neck squamous cell carcinomas (HNSCCs); however, it is …